Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
Béla Kiss, Zsolt Némethy, Károly Fazekas, Dalma Kurkó, István Gyertyán, Katalin Sághy, István Laszlovszky, Bence Farkas, Norbert Kirschner, Etelka Bolf-Terjéki, Ottilia Balázs, Balázs Lendvai Pharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, HungaryCorrespondence: Béla KissPhar...
Saved in:
Main Authors: | Kiss B (Author), Némethy Z (Author), Fazekas K (Author), Kurkó D (Author), Gyertyán I (Author), Sághy K (Author), Laszlovszky I (Author), Farkas B (Author), Kirschner N (Author), Bolf-Terjéki E (Author), Balázs O (Author), Lendvai B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cariprazine: An Antipsychotic Medication with High Therapeutic Potential
by: Wiktoria, et al.
Published: (2024) -
Revisiting the nature and pharmacodynamics of tacrolimus metabolites
by: Rudy Mevizou, et al.
Published: (2024) -
Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
by: Marcin Siwek, et al.
Published: (2024) -
A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
by: Caccia S, et al.
Published: (2013) -
New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
by: Werner FM, et al.
Published: (2015)